Pruritus in Bolognia

  • Upload
    ri

  • View
    215

  • Download
    0

Embed Size (px)

Citation preview

  • 8/4/2019 Pruritus in Bolognia

    1/3

    Bolognia: Dermatology, 2nd ed.

    SECTION TWO PRURITUS

    Chapter 6 Cutaneous NeurophysiologyGil Yosipovitch,

    Aerlyn G Dawn,

    Malcolm Greaves

    Key features

    A distinct subset of nociceptive C neurons has been identified that specifically

    transmits the sensation of itch

    Itch mediators act both peripherally (e.g. histamine, proteases) and centrally (e.g.opioids) via several mechanisms

    There is overlap between chronic itch and chronic pain, including activation of

    multiple brain areas and associated neuromediators (e.g. nerve growth factor and

    neurotrophin 4)

    Significant cross-talk between cutaneous nerve fibers and the stratum corneum is a

    possible mechanism for pruritus associated with impaired barrier function (e.g.

    xerosis, atopic dermatitis)

    No specific antipruritic treatment is available; however, combination therapies that

    reduce itch sensitization and topically acting drugs that counteract the responsiblemediators are promising treatment strategies

    INTRODUCTION

    The skin is a sensory organ with a dense network of highly specialized afferent sensory

    nerves and efferent autonomic nerve branches. Nerve fibers are found at all levels of the skin

    and transmit sensations including temperature, touch, vibration, pressure, itch and pain (Table

    6.1). Neuropeptides (e.g. nerve growth factor, substance P) are secreted from these nerve

    fibers and several exert immunologic effects. Itch (syn. pruritus) is the dominant symptom of

    skin disease; almost all inflammatory skin diseases can have associated pruritus. Itch is a

    multidimensional phenomenon with sensory discriminative, cognitive, evaluative andmotivational components. In most instances, itch results from interactions that involve the

    brainskin axis.

    Table 6.1 -- Primary afferent neurons that innervate the skin.

    PRIMARY AFFERENT NEURONS THAT INNERVATE THE SKIN

    Fiber Diameter Myelination Conduction velocity Respond to

    A-beta (A) Large + >30 m/s Light touch

    Moving stimuli

    A-delta (A) Small + 230 m/s Pain (nociceptors)

  • 8/4/2019 Pruritus in Bolognia

    2/3

    PRIMARY AFFERENT NEURONS THAT INNERVATE THE SKIN

    Fiber Diameter Myelination Conduction velocity Respond to

    Thermal

    Mechanical

    Chemical, including pruritogens

    C Small

  • 8/4/2019 Pruritus in Bolognia

    3/3

    Pruritus is the most common complaint of patients with dermatologic disease

    Pruritus can occur with or without skin lesions, and may represent dermatologic or

    systemic disorders

    Pruritus is a symptom of various complex pathogenic mechanisms that cannot be

    attributed to one specific cause or disease

    Pruritus should challenge the dermatologist to search for any underlying etiology

    Management of pruritus can often be achieved by implementing specific and non-

    specific treatments

    INTRODUCTION

    Pruritus can be defined subjectively as a poorly localized, non-adapting, usually unpleasant

    sensation which elicits a desire to scratch. The biologic purpose of pruritus is to provoke

    scratching in order to remove a pruritogen, a response likely to have originated when most

    pruritogens were parasites.

    Pruritus is the most common dermatologic symptom. It can arise from a primary cutaneous

    disorder but may also be a symptom of an underlying systemic disease in an estimated 10%

    to 50% of patients[1]

    . Diagnoses to consider include metabolic disorders, hematologic disease,

    malignancy, HIV infection, a complication of pharmacologic therapy, and neuropsychiatric

    disorders (see Ch. 8). In some patients, pruritus can occur in the absence of visible skin signs.

    To date, there is no definitive classification system for pruritus, based on either clinical

    features or pathophysiology, but a possible scheme has recently been proposed[2,3,3a]

    . While

    the limited understanding of the pathogenesis of pruritus has hampered the development of

    adequate therapies, as reviewed in Chapter 6, recent discoveries provide hope for morespecific therapies in the future[4]

    .

    When a patient complains of pruritus, there is a rational way to assemble the myriad of

    etiologies into finite groups, to evaluate the patient in a thoughtful manner, and then to

    correct the underlying cause (if possible) and treat the pruritus with currently available

    therapies.

    Copyright 2008 Elsevier Inc. All rights reserved. - www.mdconsult.com